Theodore A Gooley

Theodore A Gooley

UNVERIFIED PROFILE

Are you Theodore A Gooley?   Register this Author

Register author
Theodore A Gooley

Theodore A Gooley

Publications by authors named "Theodore A Gooley"

Are you Theodore A Gooley?   Register this Author

46Publications

968Reads

10Profile Views

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

Biol Blood Marrow Transplant 2017 Sep 30;23(9):1509-1514. Epub 2017 Jun 30.

Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Medical Oncology, University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481669PMC
September 2017

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.

Blood 2017 08 11;130(9):1170-1172. Epub 2017 Jul 11.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-771121DOI Listing
August 2017

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

Biol Blood Marrow Transplant 2016 07 6;22(7):1227-1233. Epub 2016 Apr 6.

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington Medical Center/Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999078PMC
July 2016

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Blood 2014 Dec 16;124(26):3996-4003. Epub 2014 Oct 16.

Cancer and Inflammation Program, SAIC Frederick, Inc., Frederick National Laboratories for Cancer Research, Frederick, MD; and Ragon Institute of the Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-599969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271183PMC
December 2014

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

Blood 2014 Jul 5;124(2):287-95. Epub 2014 May 5.

Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Department of Biostatistics, University of Washington School of Public Health, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-01-550566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093684PMC
July 2014

A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

Cancer Res 2014 Feb 26;74(4):1179-89. Epub 2013 Dec 26.

Authors' Affiliations: Clinical Research Division, Fred Hutchinson Cancer Research Center; Departments of Medicine, Radiation Oncology, and Laboratory Medicine, University of Washington, Seattle; and Dade Moeller Health Group, Richland, Washington.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/74/4/1179.full.pdf
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-1589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970848PMC
February 2014

Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques.

PLoS One 2013 13;8(2):e56268. Epub 2013 Feb 13.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0056268PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572023PMC
August 2013

MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.

Sci Transl Med 2012 Jul;4(144):144ra101

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3003974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633562PMC
July 2012

The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.

Blood 2010 Sep 18;116(13):2304-14. Epub 2010 Jun 18.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-09-242313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953837PMC
September 2010

Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers.

Clin Immunol 2007 Dec 29;125(3):275-80. Epub 2007 Oct 29.

Tumor Vaccine Group, Division of Oncology, University of Washington, Seattle 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2007.08.006DOI Listing
December 2007

Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.

J Clin Oncol 2005 May 11;23(15):3439-46. Epub 2005 Apr 11.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Ave N, D3-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.694DOI Listing
May 2005

Adenovirus nephritis in hematopoietic stem-cell transplantation.

Transplantation 2004 Apr;77(7):1049-57

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-4417, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.tp.0000122421.71556.71DOI Listing
April 2004

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

Blood 2004 Jan 11;103(1):347-52. Epub 2003 Sep 11.

Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-07-2603DOI Listing
January 2004

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.

Clin Cancer Res 2003 Nov;9(15):5559-65

Tumor Vaccine Group, Division of Oncology, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
November 2003

Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines.

J Clin Oncol 2002 Jun;20(11):2624-32

Division of Oncology and Department of Dermatology, University of Washington, Seattle 98195-6527, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2002.06.171
Publisher Site
http://dx.doi.org/10.1200/JCO.2002.06.171DOI Listing
June 2002